Buy Full Version
"Animal Vaccines Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Animal Vaccines Market by Product Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines) and Animal Type (Companion animals, Cattle, Fish, Pigs, Poultry, and Sheep]: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Pharmaceuticals	A01988	Pages: 197	Mar 2019 \| 8189 Views
Author(s) : Tenzin Kunsel and Onkar Sumant	Tables: 90	Charts: 42	Formats*:

Animal Vaccines Market Outlook - 2025

The global animal vaccines market size was $8,059 million in 2017, and is estimated to reach $12,845 million by 2025, registering a CAGR of 5.9% from 2018 to 2025. Animal vaccines control the transmission diseases, thus providing protection to animal and human health, which is essential considering the public dependency on animals. Animals serve as an important source of food, meat, milk, protein, and other commercial products such as leather and wool. Most commonly used veterinary vaccines include rabies vaccines, foot & mouth diseases vaccines, and equine influenza virus vaccines, which prevent the transmission of infectious agents by mimicking the naturally acquired immunity. Constant development of vaccines is essential with rise in emergence of different animal diseases. Increase in pet ownership has significantly accelerated the growth of this market.

The animal vaccines market is to grow at a steady pace due to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, surge in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the animal vaccines market growth. For instance, in August 2016, Elanco invested two-thirds of the budget for food‐animal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines has led to the emergence of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 that prevents against infectious bronchitis virus (IBV).

However, lack of animal health awareness and possibility of adverse impact on veterinary vaccines on human and other animal health can restrain the growth for animal vaccines market. Furthermore, the advanced in vaccine products and production of animal vaccines for hybrid animals can help to open new avenue for the growth of animal vaccines market.

Get more information on this report : Request Sample Pages

Product Type segment review

The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the animal vaccines market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Attenuated vaccines segment dominated the product type segment with maximum share in 2017 in the animal vaccines market size. Attenuated vaccines can provide stronger immunity as compared to other vaccines by activating a wide range of immune response. Moreover, it helps reduce the need for booster vaccines, can be administered via oral route, and induces long-lasting and rapid onset of immunity, which positively contributes toward the growth of animal vaccines market.

Get more information on this report : Request Sample Pages

Animal Type segment review

Based on animal type, the animal vaccines market is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is subsegmented into dogs, cats, and others. Cattle segment contributed the maximum revenue in 2017 for the growth of animal vaccines market, attributable to increase in consumption of meat, milk, and dairy products, making sustainable animal health a vital aspect in disease management. However, companion animal segment is expected to be the fastest growing segment as a large number of these animals are commonly in contact with humans and the infections such as rabies can affect humans too. Moreover, increase in the number of adoption of these companion animals and rise in awareness regarding the importance of vaccines for dogs and cats help to fuel the market growth.

Get more information on this report : Request Sample Pages

Region segment review

Based on region, the animal vaccines market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest revenue in the global animal vaccines market. This is attributable to the high adoption of companion animals, rise in the consumption of meat and milk, and growing awareness regarding the benefits of using animal vaccines. Asia-Pacific possesses high market potential that could affect the animal vaccines market trends due to increase in pet ownership and rise in incidence of various zoonotic diseases. Moreover, ongoing research on innovative vaccine production technology has increased due to high demand for animal-based food products and companion animals. In addition, increase in investments in animal healthcare companies has improved the production of innovative vaccines.

Get more information on this report : Request Sample Pages

The animal vaccines market analysis in Saudi Arabia is projected to grow at a high CAGR during the forecast period. In addition, the U.S. is a mature market for the animal vaccines, as it holds maximum animal vaccines market share in the patent registration for animal vaccines.

The report provides a comprehensive analysis of the key players operating in the animal vaccines industry. These players include Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH.

The other players that operate in animal vaccines market include Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.

Key Benefits for Animal Vaccines Market:

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.
An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

Animal Vaccines Key Market Segments:

By Product

Attenuated Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Conjugate Vaccines
Recombinant Vaccines
DNA Vaccines

By Animal Type

Companion Animals
- Dogs
- Cats
- Others
Cattle
Fish
Pigs
Poultry
Sheep

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
LAMEA
- Brazil
- Turkey
- Venezuela
- Saudi Arabia
- Rest of LAMEA

CHAPTER 1: INTRODUCTION

1.1.   Report Description
1.2.   Key Benefits
1.3.   Key Market Segments
1.4.   Research Methodology

1.4.1.   Secondary research
1.4.2.   Primary research
1.4.3.   Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Government Regulations

3.3.1. Center for Veterinary Biologics (CVB)

3.4.   Top player positioning
3.5.   Porter’s five forces analysis
3.6.   Market dynamics

3.6.1. Drivers

3.6.1.1.   Growth in demand for pet insurance
3.6.1.2.   Increase in prevalence of animal diseases
3.6.1.3.   Growth in ownership of companion animal
3.6.1.4.   Rise in animal health expenditure

3.6.2. Restraints

3.6.2.1. Highly competitive meat and milk prices
3.6.2.2. Adverse impact of veterinary vaccines on human and animal health

3.6.3. Opportunities

3.6.3.1. Advancement in vaccine products
3.6.3.2. Increase in demand for hybrid animal

CHAPTER 4: ANIMAL VACCINES MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Attenuated Vaccines

4.2.1.   Key market trends
4.2.2.   Key growth factors and opportunities
4.2.3.   Market size and forecast
4.2.4.   Market analysis, by country

4.3. Inactivated Vaccines

4.3.1.   Key market trends
4.3.2.   Key growth factors and opportunities
4.3.3.   Market size and forecast
4.3.4.   Market analysis, by country

4.4. Subunit Vaccines

4.4.1.   Key market trends
4.4.2.   Key growth factors and opportunities
4.4.3.   Market size and forecast
4.4.4.   Market analysis, by country

4.5. Toxoid Vaccines

4.5.1.   Key market trends
4.5.2.   Key growth factors and opportunities
4.5.3.   Market size and forecast
4.5.4.   Market analysis, by country

4.6. Conjugate Vaccines

4.6.1.   Key market trends
4.6.2.   Key growth factors and opportunities
4.6.3.   Market size and forecast
4.6.4.   Market analysis, by country

4.7. Recombinant Vaccines

4.7.1.   Key market trends
4.7.2.   Key growth factors and opportunities
4.7.3.   Market size and forecast
4.7.4.   Market analysis, by country

4.8. DNA Vaccines

4.8.1.   Key market trends
4.8.2.   Key growth factors and opportunities
4.8.3.   Market size and forecast
4.8.4.   Market analysis, by country

CHAPTER 5: ANIMAL VACCINES MARKET, BY ANIMAL TYPE

5.1. Overview

5.1.1. Market size and forecast

5.2. Companion animal

5.2.1. Market size and forecast, by type

5.2.1.1. Dogs

5.2.1.1.1. Market size and forecast

5.2.1.2. Cats

5.2.1.2.1. Market size and forecast

5.2.1.3. Other Companion animal vaccines segment

5.2.1.3.1. Market size and forecast

5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country

5.3. Cattle

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Fish

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

5.5. Pigs

5.5.1. Market size and forecast
5.5.2. Market analysis, by country

5.6. Poultry

5.6.1. Market size and forecast
5.6.2. Market analysis, by country

5.7. Sheep

5.7.1. Market size and forecast
5.7.2. Market analysis, by country

CHAPTER 6: ANIMAL VACCINES MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1.   Key market trends
6.2.2.   Key growth factors and opportunities
6.2.3.   Market size and forecast, by product
6.2.4.   Market size and forecast, by animal
6.2.5.   Market size and forecast, by country

6.2.5.1.   U.S. market size and forecast, by product
6.2.5.2.   U.S. market size and forecast, by animal
6.2.5.3.   Canada market size and forecast, by product
6.2.5.4.   Canada market size and forecast, by animal
6.2.5.5.   Mexico market size and forecast, by product
6.2.5.6.   Mexico market size and forecast, by animal

6.3. Europe

6.3.1.   Key market trends
6.3.2.   Key growth factors and opportunities
6.3.3.   Market size and forecast, by product
6.3.4.   Market size and forecast, by animal
6.3.5.   Market size and forecast, by country

6.3.5.1.   Germany market size and forecast, by product
6.3.5.2.   Germany market size and forecast, by animal
6.3.5.3.   France market size and forecast, by product
6.3.5.4.   France market size and forecast, by animal
6.3.5.5.   UK market size and forecast, by product
6.3.5.6.   UK market size and forecast, by animal
6.3.5.7.   Italy market size and forecast, by product
6.3.5.8.   Italy market size and forecast, by animal
6.3.5.9.   Rest of Europe market size and forecast, by product
6.3.5.10.   Rest of Europe market size and forecast, by animal

6.4. Asia-Pacific

6.4.1.   Key market trends
6.4.2.   Key growth factors and opportunities
6.4.3.   Market size and forecast, by product
6.4.4.   Market size and forecast, by animal
6.4.5.   Market size and forecast, by country

6.4.5.1.   Japan market size and forecast, by product
6.4.5.2.   Japan market size and forecast, by animal
6.4.5.3.   China market size and forecast, by product
6.4.5.4.   China market size and forecast, by animal
6.4.5.5.   Australia market size and forecast, by product
6.4.5.6.   Australia market size and forecast, by animal
6.4.5.7.   India market size and forecast, by product
6.4.5.8.   India market size and forecast, by animal
6.4.5.9.   South Korea market size and forecast, by product
6.4.5.10.   South Korea market size and forecast, by animal
6.4.5.11.   Rest of Asia-Pacific market size and forecast, by product
6.4.5.12.   Rest of Asia-Pacific market size and forecast, by animal

6.5. LAMEA

6.5.1.   Key market trends
6.5.2.   Key growth factors and opportunities
6.5.3.   Market size and forecast, by product
6.5.4.   Market size and forecast, by animal
6.5.5.   Market size and forecast, by country

6.5.5.1.   Brazil market size and forecast, by product
6.5.5.2.   Brazil market size and forecast, by animal
6.5.5.3.   Saudi Arabia market size and forecast, by product
6.5.5.4.   Saudi Arabia market size and forecast, by animal
6.5.5.5.   Rest of LAMEA market size and forecast, by product
6.5.5.6.   Rest of LAMEA market size and forecast, by animal

CHAPTER 7: COMPANY PROFILES

7.1. Anicon Labor GmbH

7.1.1.   Company overview
7.1.2.   Company snapshot
7.1.3.   Operating business segments
7.1.4.   Product portfolio

7.2. Boehringer Ingelheim GmbH

7.2.1.   Company overview
7.2.2.   Operating business segments
7.2.3.   Business performance

7.3. Ceva Santé Animale

7.3.1.   Company overview
7.3.2.   Company snapshot
7.3.3.   Product portfolio
7.3.4.   Business performance
7.3.5.   Key strategic moves & developments, 2014-2016

7.4. Hygieia Biological Laboratories

7.4.1.   Company overview
7.4.2.   Company snapshot
7.4.3.   Operating business segments
7.4.4.   Product portfolio

7.5. Merck & company Inc.

7.5.1.   Company overview
7.5.2.   Company snapshot
7.5.3.   Operating business segments
7.5.4.   Product portfolio
7.5.5.   Business performance
7.5.6.   Key strategic moves and developments

7.6. Romvac company S.A.

7.6.1.   Company overview
7.6.2.   Company snapshot
7.6.3.   Operating business segments
7.6.4.   Product portfolio

7.7. Sanofi S.A.

7.7.1.   Company overview
7.7.2.   Company snapshot
7.7.3.   Operating business segments
7.7.4.   Product portfolio
7.7.5.   Business performance
7.7.6.   Key strategic moves and developments

7.8. Vaxxinova Gmbh-Germany

7.8.1.   Company overview
7.8.2.   Company snapshot
7.8.3.   Operating business segments
7.8.4.   Product portfolio
7.8.5.   Key strategic moves and developments

7.9. Virbac S.A

7.9.1.   Company overview
7.9.2.   Company snapshot
7.9.3.   Operating business segments
7.9.4.   Product portfolio
7.9.5.   Business performance

7.10. Zoetis Inc.

7.10.1.   Company overview
7.10.2.   Company snapshot
7.10.3.   Operating business segments
7.10.4.   Product portfolio
7.10.5.   Business performance
7.10.6.   Key strategic moves & developments, 2015-2017

LIST OF TABLES

TABLE 01.   GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE 2017-2025, ($MILLION)
TABLE 02.   ATTENUATED ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 03.   INACTIVATED ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 04.   SUBUNIT ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 05.   TOXOID ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 06.   CONJUGATE ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 07.   RECOMBINANT ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 08.   DNA ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 09.   GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 10.   COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2017-2025, ($MILLION)
TABLE 11.   COMPANION ANIMAL VACCINES MARKET, BY REGION, 2017-2025, ($MILLION)
TABLE 12.   ANIMAL VACCINES MARKET FOR CATTLE, BY REGION, 2017-2025, ($MILLION)
TABLE 13.   ANIMAL VACCINES MARKET FOR FISH, BY REGION, 2017-2025, ($MILLION)
TABLE 14.   ANIMAL VACCINES MARKET FOR PIGS, BY REGION, 2017-2025, ($MILLION)
TABLE 15.   ANIMAL VACCINES MARKET FOR POULTRY, BY REGION, 2017-2025, ($MILLION)
TABLE 16.   ANIMAL VACCINES MARKET FOR SHEEP, BY REGION, 2017-2025, ($MILLION)
TABLE 17.   ANIMAL VACCINES MARKET, BY GEOGRAPHY 2017-2025, ($MILLION)
TABLE 18.   NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 19.   NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 20.   NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY, 2017-2025, ($MILLION)
TABLE 21.   U.S. ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 22.   U.S. VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 23.   CANADA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 24.   CANADA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 25.   MEXICO ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 26.   MEXICO VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 27.   EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 28.   EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 29.   EUROPE ANIMAL VACCINES MARKET, BY COUNTRY, 2017-2025, ($MILLION)
TABLE 30.   GERMANY ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 31.   GERMANY VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 32.   FRANCE ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 33.   FRANCE VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 34.   UK ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 35.   UK VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 36.   ITALY ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 37.   ITALY VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 38.   REST OF EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 39.   REST OF EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 40.   ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 41.   ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 42.   ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY, 2017-2025, ($MILLION)
TABLE 43.   JAPAN ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 44.   JAPAN VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 45.   CHINA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 46.   CHINA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 47.   AUSTRALIA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 48.   AUSTRALIA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 49.   INDIA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 50.   INDIA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 51.   SOUTH KOREA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 52.   SOUTH KOREA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 53.   REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 54.   REST OF ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 55.   LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 56.   LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 57.   LAMEA ANIMAL VACCINES MARKET, BY COUNTRY, 2017-2025, ($MILLION)
TABLE 58.   BRAZIL ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 59.   BRAZIL VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 60.   SAUDI ARABIA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 61.   SAUDI ARABIA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 62.   REST OF LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2017-2025, ($MILLION)
TABLE 63.   REST OF LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2017-2025, ($MILLION)
TABLE 64.   ANICON: COMPANY SNAPSHOT
TABLE 65.   ANICON: OPERATING SEGMENTS
TABLE 66.   ANICON: PRODUCT PORTFOLIO
TABLE 67.   BOEHRINGER: COMPANY SNAPSHOT
TABLE 68.   BOEHRINGER: OPERATING SEGMENTS
TABLE 69.   CEVA: COMPANY SNAPSHOT
TABLE 70.   CEVA: PRODUCT PORTFOLIO
TABLE 71.   HYGIEIA: COMPANY SNAPSHOT
TABLE 72.   HYGIEIA: OPERATING SEGMENTS:
TABLE 73.   HYGIEIA: PRODUCT PORTFOLIO
TABLE 74.   MERCK: COMPANY SNAPSHOT
TABLE 75.   MERCK: OPERATING SEGMENTS
TABLE 76.   MERCK: PRODUCT PORTFOLIO
TABLE 77.   ROMVAC: COMPANY SNAPSHOT
TABLE 78.   ROMVAC: OPERATING SEGMENTS
TABLE 79.   ROMVAC: PRODUCT PORTFOLIO
TABLE 80.   SANOFI: COMPANY SNAPSHOT
TABLE 81.   SANOFI: OPERATING SEGMENTS
TABLE 82.   SANOFI: PRODUCT PORTFOLIO
TABLE 83.   VAXXINOVA: COMPANY SNAPSHOT
TABLE 84.   VAXXINOVA: OPERATING SEGMENTS
TABLE 85.   VAXXINOVA: PRODUCT PORTFOLIO
TABLE 86.   VIRBAC: COMPANY SNAPSHOT
TABLE 87.   VIRBAC: OPERATING SEGMENTS
TABLE 88.   VIRBAC: PRODUCT PORTFOLIO
TABLE 89.   ZOETIS: COMPANY SNAPSHOT
TABLE 90.   ZOETIS: OPERATING SEGMENTS
TABLE 91.   ZOETIS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.   ANIMAL VACCINES MARKET: SEGMENTATION
FIGURE 02.   TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2017–2019)
FIGURE 03.   TOP INVESTMENT POCKETS: ANIMAL VACCINES MARKET, BY ANIMAL TYPE
FIGURE 04.   TOP PLAYER POSITIONING, 2017
FIGURE 05.   LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06.   MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.   MODERATE THREAT OF SUBSTITUTION
FIGURE 08.   MODERATE THREAT OF NEW ENTRANT
FIGURE 09.   HIIGH COMPETITIVE RIVALRY
FIGURE 10.   COMPARATIVE SHARE ANALYSIS OF ATTENUATED ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11.   COMPARATIVE SHARE ANALYSIS OF INACTIVATED ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 12.   COMPARATIVE SHARE ANALYSIS OF SUBUNIT ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 13.   COMPARATIVE SHARE ANALYSIS OF TOXOID ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 14.   COMPARATIVE SHARE ANALYSIS OF CONJUGATE ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15.   COMPARATIVE SHARE ANALYSIS OF RECOMBINANT ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16.   COMPARATIVE SHARE ANALYSIS OF DNA ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 17.   ANIMAL VACCINES MARKET FOR DOGS, 2017–2025 ($MILLION)
FIGURE 18.   ANIMAL VACCINES MARKET FOR CATS, 2017–2025 ($MILLION)
FIGURE 19.   ANIMAL VACCINES MARKET FOR OTHER COMPANION ANIMAL, 2017–2025 ($MILLION)
FIGURE 20.   COMPARATIVE SHARE ANALYSIS OF COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21.   COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR CATTLE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22.   COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR FISH, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23.   COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR PIG, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24.   COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR POULTRY, BY COUNTRY, 2017 & 2025 (%)
FIGURE 25.   COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR SHEEP, BY COUNTRY, 2017 & 2025 (%)
FIGURE 26.   BOEHRINGER: REVENUE, 2015–2017 ($MILLION)
FIGURE 27.   BOEHRINGER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28.   BOEHRINGER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 29.   CEVA: NET SALES, 2015–2017 ($MILLION)
FIGURE 30.   CEVA: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 31.   MERCK: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.   MERCK: REVENUE SHARE BY PRODUCT, 2018 (%)
FIGURE 33.   MERCK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34.   SANOFI: NET SALES, 2015–2017 ($MILLION)
FIGURE 35.   SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36.   SANOFI: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 37.   VIRBAC: REVENUE, 2015–2017 ($MILLION)
FIGURE 38.   VIRBAC: REVENUE SHARE BY PRODUCT CATEGORY, 2017 (%)
FIGURE 39.   VIRBAC: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 40.   ZOETIS: NET SALES, 2015–2017 ($MILLION)
FIGURE 41.   ZOETIS: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 42.   ZOETIS: REVENUE SHARE BY REGION, 2017 (%)

The animal vaccines market is expected to witness moderate growth owing to increase in incidence of various animal diseases such as rabies and Newcastle disease. The demand for animal vaccines is anticipated to increase owing to high nutritional value of animal-derived food products such as meat & milk and rise in need for companion animals. Furthermore, rise in emergence of antibiotic-resistant microorganisms due to high usage of antibiotics among animals is expected to fuel the growth of the global animal vaccines market.

Advancement in production of vaccines is expected to have a positive impact on the market growth. The advancement in the field of molecular biology has increased the production of DNA & recombinant vaccines. Advancement in production of plant-based animal vaccines reduces the production cost and makes the vaccines safer and more stable for usage in animals.

The employment of technologically advanced animal vaccines is highest in North America, owing of the increase in adoption of these products and rise in disposable income. The growth of the market is driven by rise in disposable income, increase in demand for meat in developing countries such as China and India, and growth in adoption of companion animals. The cattle segment significantly contributes toward the market growth owing to the rise in demand for dairy products.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,296 Five User License ~~$6,450~~ $4,838 Enterprise User License ~~$8,995~~ $6,297

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com